Ophthalmic formulation for treating myopia comprising dopamine agonist and cyclodextrin
US5814638A · kind A · utility
19Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1996 |
| Grant date | Sep 29, 1998 |
| Priority date | — |
| Expiry date | Oct 2, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ophthalmic formulation for treating myopia, which comprises a dopamine agonist and cyclodextrin or its derivative in combination with a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.